type sequence filename description text html head head body bgcolor ffffff link blue vlink purple style font family time roman align right style margin text align right font size face time roman style font size font weight bold exhibit font align right style margin text align right font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold license agreement font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size this license agreement agreement made effective april effective date between michigan life therapeutic corporation organized existing under michigan with office shadford road arbor licensee pfizer corporation organized existing under delaware with office east font font size style font size position relative font street york pfizer licensee pfizer from time time individually referred party collectively referred party style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold recital font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas pfizer owns certain patent hereinafter referred defined license patent font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas licensee wish obtain pfizer wish grant certain license relating these license patent term condition forth herein font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size therefore consideration mutual agreement covenant forth herein other good valuable consideration receipt sufficiency which party hereby acknowledge party intending legally bound hereby agree foregoing follows font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font definition style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font affiliate mean with respect party person that control controlled under common control with that party purpose this definition control shall refer nbsp possession directly indirectly power direct management policy entity whether through ownership voting security contract otherwise nbsp ownership directly indirectly fifty percent more voting security such entity style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font applicable mean applicable statute rule regulation guideline including without limitation good manufacturing practice applicable standard guideline promulgated appropriate regulatory authority style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font business mean other than saturday sunday which commercial bank located york york authorized required remain closed style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font calendar quarter mean three nbsp month period commencing effective date each successive three nbsp month period thereafter style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font calendar year mean twelve month period commencing effective date each successive twelve month period thereafter style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font commercialize commercialization mean manufacture sale market promote distribute sell style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font commercially reasonable effort mean nbsp with respect further development product effort expenditure required obtain regulatory approval securing patent that comparable licensee product that similar stage development nbsp with respect commercialization product effort expenditure that comparable those used licensee product that similar commercial potential style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font common stock mean share common stock licensee value share style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font control controlled mean with respect intellectual property right legal authority right whether ownership license otherwise party grant license permitted sublicense under such intellectual property right other party without breaching term agreement with third party style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font convertible security mean bond debenture note other evidence indebtedness warrant share other security convertible into exercisable exchangeable common stock excluding option style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font develop development mean conduct research development activity necessary obtain regulatory approval style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font mean united state food drug administration successor federal agency thereto style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font first commercial sale mean first sale consumption general public product following receipt regulatory approval such product from federal drug authority relevant foreign counterpart territory style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font fully diluted share mean number share common stock that would issued outstanding immediately following issuance subsequent financing security plus share common stock issuable upon conversion such subsequent financing security plus share common stock that issuable upon exercise conversion other option convertible security outstanding immediately following issuance such subsequent financing security style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font gaap mean generally accepted accounting principle forth opinion pronouncement accounting principle board american institute certified public accountant statement pronouncement financial accounting standard board style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font mean nbsp investigational drug application filed with authorization investigation product nbsp foreign equivalent filed with applicable regulatory authority relevant regulatory jurisdiction territory applicable style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font intellectual property right mean trade secret copyright patent other patent right trademark moral right know other intellectual property proprietary right known hereafter recognized jurisdiction style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font license patent mean patent secured listed schedule right patent term contained herein style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font milestone mean each milestone forth section nbsp style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font mean nbsp drug application biologic license application filed with authorization marketing product nbsp foreign equivalent filed with applicable regulatory authority other country regulatory jurisdiction territory applicable style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font sale mean consolidated gross amount licensed product invoiced licensee affiliate sale return allowance actually paid granted accrued including trade quantity cash discount chargebacks rebate customary trade discount actually taken outbound freight value added sale custom excise duty sale shall determined from consolidated book record licensee affiliate licensee case maybe maintained accordance with gaap consistently applied style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size following principle shall apply calculation sale font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font case sale product which invoiced delivered before invoice sale shall calculated time shipment when product paid paid before shipment invoice style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font case sale other disposal product cash consideration sale shall calculated fair market price product country sale disposal style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font sale shall reduced sale combination product purpose this subsection combination product mean pharmaceutical product containing nbsp product nbsp more other therapeutically active ingredient style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font unless otherwise specified herein sale shall calculated accordance with gaap generally consistently applied style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font option mean right option warrant subscribe purchase otherwise acquire common stock convertible security style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font patent right mean nbsp patent patent application listed schedule nbsp divisionals continuation continuation part that claim priority patent patent application described subsection nbsp patent that have issued future issue from foregoing patent application subsection nbsp including utility model design patent certificate invention nbsp reissue renewal extension addition foregoing nbsp foreign equivalent foregoing style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font person mean individual corporation partnership limited liability company trust business trust association joint stock company joint venture pool syndicate sole proprietorship unincorporated organization governmental authority other form entity specifically listed herein style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font permitted licensee mean third party affiliate licensee respect whom licensee received prior written consent from pfizer assign right license patent style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font product mean gemcabene calcium further identified compound along with certain intellectual property information other related asset style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font regulatory approval mean with respect product country jurisdiction approval including where required pricing reimbursement approval registration license authorization that required applicable regulatory authority market sell product such country jurisdiction style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font regulatory authority mean governmental agency authority responsible granting regulatory approval product territory style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font regulatory filing mean with respect product submission regulatory authority appropriate regulatory application including without limitation submission regulatory advisory style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size board marketing authorization application supplement amendment thereto font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font royalty term mean with respect product each country territory period commencing effective date expiring upon later expiration abandonment last valid claim patent right including patent term extension supplemental protection certificate such country territory style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font subsequent financing security mean share licensee series nbsp preferred stock share other convertible preferred equity security hereafter issued sold licensee issued sold licensee contingent upon occurrence milestone similar event upon satisfaction more condition bona fide length equity financing transaction with unrelated third party style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font territory mean entire world style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font third party mean person other than party affiliate party style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font trademark meaning forth section nbsp style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font mean make have made sell offer sale import style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font valid claim mean either nbsp claim issued unexpired patent included within patent right which been permanently revoked declared unenforceable invalid unreserved unappealable unreversed unappealed decision court other appropriate body competent jurisdiction nbsp claim pending patent application included within patent right which claim filed good faith been abandoned finally disallowed without possibility appeal refiling such application style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font license grant style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font license grant patent right style margin font size face time roman style font size nbsp font style margin font size face time roman style font size subject term condition this agreement pfizer hereby grant licensee exclusive royalty bearing right license under patent right product within territory subject term condition this agreement pfizer hereby grant licensee royalty bearing right license license patent purpose development commercialization product within territory font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font retained right licensee acknowledges agrees that pfizer retains right make have made product other purpose style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font residual pfizer purpose residual resulting from access work with product know used herein residual mean information tangible form which retained person have access product know including idea concept know technique contained therein style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font additional right nothing this agreement shall construed confer right upon licensee implication estoppel otherwise technology intellectual property right pfizer affiliate other than license patent regardless whether such technology intellectual property right shall dominant subordinate license patent style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font transfer documentation style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font pfizer agrees maintain currently existing record relating license right product including regulatory record period nbsp month from effective date event that licensee wish access these pfizer will reasonable effort nbsp make available licensee licensee cost currently available record which with effective date licensee understands that cost such retrieval will approximately style margin font size face time roman style font size nbsp font style margin font size face time roman style font size notwithstanding foregoing event shall pfizer provide nbsp data record that include technology product other than product nbsp laboratory notebook pfizer internal team meeting minute communication personal note internal correspondence that related product provided that pfizer will provide licensee relevant summary information that pertains subsection nbsp nbsp extent such information nbsp exists effective date nbsp retained pfizer nbsp reasonably retrievable pfizer font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font development commercialization style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font development licensee shall itself through affiliate commercially reasonable effort develop product territory connection with effort develop product licensee shall bear responsibility expense filing regulatory filing licensee name obtaining regulatory approval product licensee will undertake such activity sole expense shall provide pfizer report regarding licensee progress within thirty following expiration each calendar year style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font commercialization licensee shall itself through affiliate permitted licensee commercially reasonable effort commercialize product territory licensee will undertake such activity sole style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size expense expressly clarified that licensee shall solely liable meet execute compliance related manufacture distribution sale licensed product font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font payment term style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font consideration license right granted licensee hereunder licensee shall pfizer payment following manner style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font partial consideration right granted pfizer licensee agrees that upon issuance subsequent financing security time request pfizer licensee shall issue pfizer number share common stock equal percent licensee fully diluted share such share stock consideration licensee agrees that shall take such action that reasonably requested pfizer that otherwise necessary required give effect foregoing issuance stock pfizer licensee represents warrant pfizer that stock consideration when issued delivered accordance with term hereof will duly validly issued fully paid assessable will issued compliance with applicable federal state security regarding registration qualification such security will issued violation emptive right style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font milestone payment licensee shall notify pfizer soon practicable upon achievement each milestone further consideration license right granted licensee within thirty upon achievement each milestone forth below licensee shall pfizer corresponding creditable refundable milestone payment each milestone payment style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold milestone font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone payment font width valign bgcolor cceeff style background cceeff padding width style font size margin text indent font size face symbol style font size font font size face symbol style font size nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font date regulatory submission first country territory width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign style padding width style margin text indent font size face symbol style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style font size margin text indent font size face symbol style font size font font size face symbol style font size nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font date receipt regulatory approval following country width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font style margin font size face time roman style font size font style font size margin font size face time roman style font size japan font width valign style padding width style margin text indent font size face symbol style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style font size margin text indent font size face symbol style font size font font size face symbol style font size nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font year post approval first received regulatory approval country territory width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold milestone font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold milestone payment font width valign bgcolor cceeff style background cceeff padding width style font size margin text indent font size face symbol style font size font font size face symbol style font size nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp font sale milestone width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size time payment upon achieving consolidated sale font style margin font size face time roman style font size time payment when first achieving consolidated sale font style margin font size face time roman style font size time payment when first achieving consolidated sale font style margin font size face time roman style font size time payment when first achieving consolidated sale font table style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font royalty payment style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font consideration license right granted licensee hereunder licensee shall pfizer royalty forth below consolidated sale product nbsp territory collectively royalty style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold nbsp sale font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size sale equal calendar year font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size sale font width valign style padding width style margin font size face time roman style font size sale equal calendar year font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size sale font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size sale equal more than calendar year font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size sale font table style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee shall pfizer applicable royalty within thirty following expiration each calendar quarter after date first commercial sale royalty will payable country country basis commencing first commercial sale product each country until expiration royalty term such product each country style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font payment shall accompanied report that includes reasonably detailed information regarding total monthly sale calculation sale product including deduction royalty payable pfizer applicable calendar quarter including foreign exchange rate employed style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font this royalty shall payable royalty term expressly clarified that royalty income direct indirect benefit from association with permitted sublicense shall valued included purpose computing ascertaining milestone payment royalty that shall payable pfizer style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font align center style margin text align center font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font other payment licensee shall pfizer other amount under this agreement within thirty following receipt invoice style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font late payment late payment shall bear interest extent permitted date payment style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font payment method style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font payment under section nbsp that recorded currency other than dollar shall converted into dollar average daily foreign exchange rate published wall street journal other qualified source that acceptable both party calendar quarter which such payment expense occurred period than calendar quarter average daily rate published wall street journal such period style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font payment from licensee pfizer shall made wire transfer dollar credit such bank account designated pfizer writing licensee payment which fall date which business made next succeeding business style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font understood agreed between party that amount payable licensee pfizer hereunder exclusive applicable sale excise property other levy duty collectively licensee shall responsible billing collection from customer remitting appropriate taxing authority which required collect remit each party will responsible their income property style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee required make payment pfizer subject deduction withholding withholding requirement then payable licensee respect which such deduction withholding required made shall increased extent necessary ensure that pfizer receives equal which would have received such withholding requirement been applicable amount required deducted withheld shall remitted licensee accordance with applicable such withholding required under applicable paid withheld shall expense borne solely licensee style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font party agree cooperate produce timely basis form report including form nbsp reasonably requested other party connection with payment made licensee pfizer under this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font event that licensee unable adequately commercialize product license patent within period nbsp year pfizer shall have option revoking license patent favor that affiliate monies paid licensee pfizer shall remain nonrefundable style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font record audit right style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font relevant record style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font relevant record licensee shall maintain accurate financial book record pertaining licensee sale product including calculation applicable collectively relevant record licensee shall maintain relevant record longer nbsp period time required applicable nbsp three nbsp year following expiration termination this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font audit request pfizer shall have right during term twelve month thereafter engage expense independent auditor reasonably acceptable licensee examine relevant record from time time more frequently than once every twelve month necessary verify compliance with term this agreement such audit shall requested writing least seven nbsp advance shall conducted during licensee normal business hour otherwise manner that minimizes interference licensee business operation style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font audit expense pfizer shall bear expense incur connection with such audit relevant record provided however event audit reveals underpayment licensee more than period subject audit licensee shall reimburse pfizer reasonable documented pocket cost expense audit within thirty after receiving invoice thereof style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font payment deficiency audit establishes that licensee underpaid amount pfizer under this agreement then licensee shall pfizer such deficiency within thirty after receipt written notice thereof avoidance doubt such payment will considered late payment subject section style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan style font family time roman style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font intellectual property right style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font existing each party shall retain right title interest intellectual property right that owned licensed sublicensed such party prior independent this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font developed licensee shall right title interest intellectual property right that both nbsp related product nbsp conceived solely licensee affiliate permitted licensee following effective date collectively developed licensee hereby grant pfizer exclusive licensable royalty free right license under developed research development purpose clarification purpose this license commercial license style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font patent prosecution style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font patent prosecution maintenance subject pfizer right forth below licensee will responsible filing prosecuting including connection with reexamination opposition like maintaining patent right territory pfizer name licensee cost expense licensee will select qualified patent counsel corresponding foreign associate prepare file prosecute maintain patent right licensee will keep pfizer reasonably informed status patent right timely providing pfizer copy significant communication relating such patent right that received from patent office patent counsel record foreign associate style margin font size face time roman style font size nbsp font style font size margin font size face time roman style font size font weight bold assistance font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size reasonably requested pfizer writing licensee shall obtain patent term restoration licensee expense under limited drug price competition patent term restoration supplementary protection certificate their equivalent patent term extension with respect patent right united state japan europe font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font failure prosecute maintain event licensee elect forgo filing prosecution maintenance patent right licensee shall notify pfizer such election least forty five prior filing payment date other date that requires action election notice upon receipt election notice pfizer shall entitled upon written notice licensee sole discretion expense style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size file continue prosecution maintenance such patent right such country pfizer name using counsel choice expense pfizer patent right which case term patent right shall modified exclude pfizer patent right date licensee provides pfizer such election notice font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font infringement missappropriation style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font notification each party will promptly notify other party writing actual threatened infringement misappropriation other violation third party license patent territory which becomes aware third party infringement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font infringement action style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font right first enforcement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee shall have first right obligation expense control enforcement license patent against third party infringement prior commencing such action licensee shall consult with pfizer shall give consideration pfizer recommendation regarding proposed action licensee shall give pfizer timely notice proposed settlement such action instituted licensee shall without prior written consent pfizer enter into settlement that would nbsp adversely affect validity enforceability scope patent right nbsp give rise liability pfizer affiliate nbsp admit infringement patent right nbsp otherwise impair pfizer right license patent this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee obtain agreement from alleged infringer desist fails initiate infringement action within nbsp sixty following licensee receipt notice alleged infringement nbsp thirty before expiration date filing such action whichever come first pfizer shall have right sole discretion control such enforcement license patent sole expense style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font recovery recovery resulting from action relating claim third party infringement shall first applied against payment each party cost expense incurred connection therewith style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font remaining recovery shall retained received pfizer paid licensee provided nbsp however pfizer shall entitled royalty such remaining recovery applicable rate forth herein amount such remaining recovery were sale licensee calendar year which recovery were received licensee licensee fails institute action proceeding pfizer exercise right prosecute such infringement remaining recovery shall retained pfizer style font size margin text indent font size face time roman style font size font font size style font size font confidentiality style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font definition confidential information mean term provision this agreement other proprietary information data financial commercial technical nature that disclosing party affiliate supplied otherwise made available other party affiliate which nbsp disclosed writing nbsp disclosed orally summarized writing provided receiving party after disclosure know shall considered pfizer confidential information style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font obligation receiving party will protect confidential information against unauthorized disclosure third party with reasonable degree care receiving party disclose confidential information affiliate their respective director officer employee subcontractor permitted sublicense consultant attorney accountant bank investor collectively recipient have need know such information purpose related this agreement provided that receiving party shall hold such recipient written obligation confidentiality with term condition least restrictive those forth this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font exception style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font obligation under this section nbsp shall apply information extent receiving party demonstrate competent evidence that such information style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font time disclosure becomes after time disclosure known public part public domain through breach this agreement receiving party recipient whom disclosed such information style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font known otherwise possession receiving party prior time disclosure disclosing party style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font disclosed receiving party confidential basis third party entitled disclose without breaching confidentiality obligation disclosing party style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font independently developed behalf receiving party affiliate evidenced written record without access confidential information style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font restriction forth this section nbsp shall apply confidential information that receiving party required disclose under applicable court order other governmental order provided that receiving party nbsp provides disclosing party with prompt notice such disclosure requirement legally permitted nbsp affords disclosing party opportunity oppose limit secure confidential treatment such required disclosure nbsp disclosing party unsuccessful effort pursuant subsection discloses only that portion confidential information that receiving party legally required disclose advised receiving party legal counsel style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font event that pfizer wish assign pledge otherwise transfer right receive some milestone payment royalty payable hereunder pfizer disclose third party confidential information licensee connection with such proposed assignment provided that pfizer shall hold such third party written obligation confidentiality with term condition least restrictive those forth this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font right injunctive relief licensee agrees that breach this section nbsp cause irreparable harm pfizer shall entitle pfizer addition other remedy available subject term this agreement right seek injunctive relief enjoining such action style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font ongoing obligation confidentiality upon expiration termination this agreement receiving party shall shall cause recipient destroy return requested disclosing party confidential information disclosing party except copy which retained confidential file archive purpose style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font representation warranty covenant style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font representation warranty each party each party represents warrant other party effective date that style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font corporation duly organized validly existing good standing under jurisdiction formation style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font full corporate power authority execute deliver perform under this agreement taken corporate action required applicable organizational document authorize execution delivery this agreement consummation transaction contemplated this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font this agreement constitutes valid binding agreement enforceable against accordance with term style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font consent approval authorization from governmental authority other third party required obtained such party connection with this agreement have been obtained style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font execution delivery this agreement other instrument document required executed pursuant this agreement consummation transaction contemplated hereby shall nbsp conflict with result breach provision organizational document nbsp result breach agreement which party that would impair performance obligation hereunder nbsp violate applicable style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font representation warranty licensee style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee represents warrant that financial commercial capability develop commercialize product accordance with this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee represents warrant pfizer that shall comply with applicable with respect performance obligation hereunder style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font without limiting generality contained herein licensee shall comply with foreign corrupt practice modified amended licensee represents warrant that will directly indirectly offer authorize such offer payment money transfer anything value improperly seek influence government official licensee itself government official licensee represents warrant that accepted will accept future such payment transfer used herein governmental official mean nbsp elected appointed government style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin font size face time roman style font size official member ministry health nbsp employee person acting behalf government official agency enterprise performing governmental function nbsp political party font officer employee person acting behalf political party candidate public office nbsp employee person acting behalf public international organization nbsp person otherwise categorized government official under local government meant include level subdivision government local regional national administrative legislative executive licensee will update these warranty employee relative such individual becomes government official government government official becomes owner licensee style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font other warranty except expressly stated herein neither party make representation extends warranty kind either express implied statutory otherwise nbsp including limited warranty title infringement validity enforceability merchantability fitness particular purpose licensed product information provided pfizer affiliate made available basis without warranty with respect completeness compliance with regulatory standard regulation fitness particular purpose other kind warranty whether express implied style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font indemnification style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font indemnification licensee licensee agrees indemnify hold harmless defend pfizer affiliate their respective officer director employee contractor agent assigns collectively pfizer indemnitees from against claim arising resulting from nbsp development product licensee affiliate nbsp commercialization product licensee affiliate subcontractor permitted licensee nbsp negligence recklessness wrongful intentional omission licensee affiliate subcontractor permitted licensee nbsp breach licensee representation warranty covenant forth this agreement nbsp breach licensee scope license forth this agreement used herein claim mean collectively third party demand claim action proceeding whether criminal civil contract tort otherwise loss damage liability cost expense including reasonable attorney style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font event compliance term contained herein licensee hereby confirms undertakes that right provided herein licensed patent including limited document material application that maybe possession name licensee affiliate shall deemed have been irrevocably transferred back pfizer cost pfizer cost such transfer shall borne licensee style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font indemnification procedure connection with claim which pfizer seek indemnification from licensee pursuant this agreement pfizer shall nbsp give licensee prompt written notice claim provided however that failure provide such notice shall relieve licensee from liability obligation hereunder except extent material prejudice direct result such failure nbsp cooperate with licensee licensee expense connection with defense settlement claim nbsp permit licensee control defense settlement claim provided however that licensee settle claim without pfizer prior written consent which shall unreasonably withheld delayed event such settlement materially adversely impact pfizer right obligation further pfizer shall have right participate control represented suit action advisory counsel selection expense style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font limitation liability style margin font size face time roman style font size nbsp font style font size margin font size face time roman style font size font weight bold consequential damage waiver font except breach section nbsp obligation arising under section nbsp neither party shall liable indirect consequential special exemplary punitive damage nbsp including damage lost profit lost revenue regardless whether been informed possibility likelihood such damage type claim contract tort including negligence style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font term termination style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font term term this agreement shall commence effective date shall expire upon last expire royalty term style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font termination cause each party shall have right without prejudice other remedy available equity terminate this agreement event other party breach material obligation hereunder fails cure such breach within thirty receiving notice thereof provided however such breach capable being cured cured within such thirty period breaching party initiate action style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size cure such breach within such period thereafter diligently pursues such action breaching party shall have such additional period reasonable cure such breach event will such additional period exceed sixty termination party under this section nbsp shall without prejudice damage other legal equitable remedy which entitled from other party avoidance doubt licensee failure commercially reasonable effort develop commercialize product shall constitute material breach licensee under this agreement font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font termination bankruptcy event each party shall have right terminate this agreement event bankruptcy event with respect other party bankruptcy event mean occurrence following nbsp institution bankruptcy receivership insolvency reorganization other similar proceeding against party under bankruptcy insolvency other similar hereinafter effect including section chapter united state bankruptcy code amended under similar statute united state state thereof bankruptcy code where case involuntary proceeding such proceeding have been dismissed discharged within ninety after they instituted nbsp insolvency making assignment benefit creditor admittance party involuntary debt they mature nbsp institution reorganization arrangement other readjustment debt plan party involving bankruptcy code nbsp appointment receiver substantially party asset nbsp corporate action taken board director party furtherance foregoing action style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font termination challenge license patent pfizer shall have right immediately terminate this agreement time after effective date entirety country country basis event licensee affiliate their permitted licensee contest challenge support assist third party contest challenge patent office court regulatory agency other forum pfizer ownership right validity enforceability scope license patent style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font termination convenience licensee shall have right terminate this agreement convenience upon ninety prior written notice pfizer event licensee terminates convenience licensee shall pfizer early termination amount equal dollar style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font effect termination expiration style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font upon termination expiration this agreement licensee shall pfizer amount pfizer effective date termination expiration within thirty following effective date termination expiration style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font upon termination this agreement licensee shall have right sell remaining inventory product following termination this agreement long licensee fully paid royalty milestone payment permitted sublicense owed pfizer licensee otherwise material breach this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font subject this section nbsp upon termination this agreement license granted pfizer licensee shall terminate clarity termination license granted pfizer licensee shall terminate permitted sublicenses granted licensee hereunder style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font with exception termination this agreement licensee pursuant section nbsp upon termination this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee hereby grant pfizer exclusive fully paid royalty free worldwide transferable perpetual irrevocable license with right sublicense intellectual property right controlled licensee that arise from development commercialization product including without limitation developed product style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font extent permitted applicable regulatory authority licensee shall nbsp transfer pfizer regulatory filing regulatory approval held licensee with respect product nbsp extent subsection nbsp permitted applicable regulatory authority permit pfizer cross reference rely upon regulatory approval regulatory filing filed licensee with respect product style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee hereby grant pfizer fully paid royalty free worldwide transferable licensable perpetual irrevocable license trademark identifying product purpose manufacturing marketing distributing selling product used herein trademark mean registered unregistered trademark service mark trade dress trade name logo insignia domain name symbol design combination thereof style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font upon pfizer request licensee shall continue going development mutually agreed upon migration period after termination this agreement which period shall than nbsp month unless otherwise agreed party migration period during migration period licensee shall provide such knowledge transfer other training style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size pfizer affiliate third party that designated writing pfizer designated affiliate third party reasonably necessary pfizer designated affiliate third party continue such activity connection with such transfer licensee shall pfizer option nbsp transfer pfizer designated affiliate third party product cost paid licensee manufacture such product nbsp transfer pfizer designated affiliate third party licensee inventory owned licensee cost paid licensee such licensee inventory nbsp assign pfizer designated affiliate third party agreement with third party with respect development commercialization product used herein licensee inventory mean component work process produced held licensee with respect manufacture product font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font survival expiration termination this agreement shall relieve party obligation accruing hereunder prior such expiration termination without limiting foregoing provision section shall survive expiration termination this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font publicity style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font publicity style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font subject pfizer right herein neither party affiliate agent shall trademark other party affiliate press release publication other form promotional disclosure without prior written consent other party each instance style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font each party agrees issue press release other public statement whether written electronic oral otherwise disclosing existence this agreement term hereof information relating this agreement without prior written consent other party provided nbsp however that neither party will prevented from complying with duty disclosure have pursuant applicable rule nbsp recognized stock exchange long disclosing party provides other party least nbsp business prior written notice extent practicable only discloses information extent required applicable rule nbsp recognized stock exchange style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan style font family time roman style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font licensee insurance style margin text indent font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font insurance requirement licensee will maintain during term this agreement until later nbsp three nbsp year after termination expiration this agreement nbsp date that statute limitation covering claim suit that instituted personal injury based sale product have expired commercial general liability insurance from minimum best rated insurance company including contractual liability product liability clinical trial applicable with coverage limit than occurrence aggregate licensee right provide total limit required combination primary umbrella excess coverage minimum level insurance forth herein shall construed create limit licensee liability hereunder such policy shall name pfizer affiliate additional insured provide waiver subrogation favor pfizer affiliate such insurance policy shall primary contributing with respect other similar insurance policy available pfizer affiliate deductible such insurance shall assumed licensee style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font policy notification licensee shall provide pfizer with certified copy such policy original certificate insurance evidencing such insurance nbsp prior execution both party this agreement nbsp prior expiration coverage such certificate shall provide that pfizer shall given least thirty written notice prior cancellation termination change restrict coverage reduce limit afforded style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font dispute resolution style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font general except dispute which injunctive other equitable relief sought prevent unauthorized disclosure proprietary material information prevent infringement misappropriation party intellectual property right following procedure shall used resolve dispute arising connection with this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font meeting promptly after written request either party each party shall appoint designated representative meet person telephone attempt good faith resolve dispute designated representative resolve dispute within sixty business such request then executive officer each party shall meet person telephone review attempt resolve dispute good faith executive officer shall have sixty business attempt resolve dispute style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font general provision style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font assignment neither party assign right obligation under this agreement without other party prior written consent except that nbsp pfizer assign third party right receive some style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size payable hereunder nbsp each party assign right obligation under this agreement part hereof more affiliate without consent other party nbsp either party assign this agreement event change control used herein change control mean acquisition party third party sale substantially business which this agreement relates assigning party shall provide other party with prompt written notice such assignment permitted assignee pursuant clause nbsp nbsp above shall assume obligation assignor under this agreement permitted assignment shall relieve assignor liability obligation hereunder attempted assignment contravention foregoing shall void font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font severability should more provision this agreement become void unenforceable matter then such provision will ineffective only extent such prohibition invalidity without invalidating remainder this agreement party agree substitute valid enforceable provision therefore which nearly possible achieves desired economic effect mutual understanding party under this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font governing exclusive jurisdiction style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font this agreement shall governed construed under effect state york without giving effect conflict provision thereof other jurisdiction that would produce contrary result style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font court york shall have exclusive jurisdiction over action brought enforce this agreement each party hereto irrevocably nbsp submits such exclusive jurisdiction such purpose nbsp waif objection which have time laying venue proceeding brought such court nbsp waif claim that such proceeding have been brought inconvenient forum nbsp further waif right object with respect such proceeding that such court have jurisdiction over such party notwithstanding foregoing application made court competent jurisdiction with respect enforcement judgment award style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font force majeure except with respect delay nonperformance caused negligent intentional omission party delay nonperformance such party other than payment obligation under this agreement will considered breach this agreement extent such delay nonperformance caused natural disaster government civil military authority fire flood epidemic quarantine energy crisis riot other similar cause outside reasonable control style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size such party each force majeure event provided that party affected such force majeure event will promptly begin resume performance soon reasonably practicable after event abated force majeure event prevents party from performing obligation under this agreement hundred eighty more then other party terminate this agreement immediately upon written notice performing party font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font waiver amendment failure party assert right hereunder insist upon compliance with term condition this agreement shall constitute waiver that right excuse similar subsequent failure perform such term condition other party waiver shall effective unless been given writing signed party giving such waiver provision this agreement amended modified other than written document signed authorized representative each party style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font relationship party nothing contained this agreement shall deemed constitute partnership joint venture legal entity type between pfizer licensee constitute party agent other moreover each party agrees construe this agreement transaction contemplated hereby partnership purpose each party shall solely independent contractor nothing this agreement shall construed give party power authority bind commit other party style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font successor assigns this agreement shall binding upon inure benefit party hereto their respective successor permitted assigns style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font notice notice consent waiver other communication under this agreement must writing will deemed have been duly given when nbsp delivered hand with written confirmation receipt nbsp sent with written confirmation receipt provided that copy sent internationally recognized overnight delivery service receipt requested nbsp when received addressee sent internationally recognized overnight delivery service receipt requested each case appropriate address number forth below such other address number party designate written notice style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size pfizer font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font weight bold pfizer font style font size margin text indent font size face time roman style font size east font font size style font size position relative font street style margin text indent font size face time roman style font size york font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size attention general counsel font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size licensee font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size michigan life therapeutic font style margin text indent font size face time roman style font size shadford road font style margin text indent font size face time roman style font size arbor font style margin text indent font size face time roman style font size font style margin text indent font size face time roman style font size attention nbsp charles bisgaier font style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font further assurance licensee pfizer hereby covenant agree without necessity further consideration execute acknowledge deliver such other document take such other action reasonably necessary appropriate carry intent purpose this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font third party beneficiary right this agreement intended shall construed give third party interest right including without limitation third party beneficiary right with respect connection with agreement provision contained herein contemplated hereby style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font entire agreement confidentiality agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font this agreement together with schedule forth entire agreement understanding party subject matter hereof supersedes proposal oral written other prior communication between party with respect such subject matter including without limitation that certain confidentiality agreement between party dated october nbsp amendment dated january nbsp party acknowledge agree that effective date evaluation material defined disclosed pfizer affiliate pursuant shall considered pfizer confidential information subject term forth this agreement style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font event conflict between material provision this agreement schedule hereto agreement shall control style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font counterpart this agreement executed more counterpart each which shall deemed original which together shall constitute same instrument style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font cumulative remedy remedy referred this agreement intended exclusive each shall cumulative addition other remedy referred this agreement otherwise available under style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style font size margin text indent font size face time roman style font size font font size style font size font waiver rule nbsp construction each party opportunity consult with counsel connection with review drafting negotiation this agreement accordingly rule nbsp construction that ambiguity this agreement shall construed against drafting party shall apply style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size signature next page font style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size witness whereof party intending bound have caused this agreement executed their duly authorized representative effective date font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width colspan valign style padding width style margin font size face time roman style font size font weight bold michigan life therapeutic font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold pfizer font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size charles bisgaier font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size rolph font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size name font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size charles bisgaier font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size name font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size rolph font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size title font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size chief executive manager font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size title font width colspan valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size pfizer global research font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size michigan life therapeutic font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size head metabolic endocrine font height width style border none width style border none width style border none width style border none width style border none width style border none width style border none width style border none width style border none table style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan style font family time roman align right style margin text align right font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold schedule patent right font style font size margin font size face time roman style font size font weight bold font patent style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold docket number font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold former nbsp font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold country font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold application number font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold application date font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold status font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold nbsp status font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin size width noshade align left style color black style margin font size face time roman style font size information redacted pursuant confidential treatment request gemphire therapeutic under nbsp rule nbsp under security submitted separately with security exchange commission font style margin font size face time roman style font size nbsp font align center style font size margin text align center name _pb_ style margin size width noshade align left style color gemphire therapeutic folio file disk _zch user vstefan tocexistflag body html text document